05:52 AM EST, 11/12/2024 (MT Newswires) -- AstraZeneca ( AZN ) reported Q3 earnings Tuesday of $0.91 per diluted share, up from $0.88 a year earlier.

A single analyst surveyed by Capital IQ expected $0.77.

Revenue for the quarter ended Sept. 30 was $13.57 billion, compared with $11.49 billion a year earlier.

Analysts surveyed by Capital IQ expected $13.08 billion.

The company said it raised its 2024 core EPS forecast to a high-teens percentage from a mid-teens percentage expected previously. Analysts polled by Capital IQ expect normalized EPS of $4.07.

Total revenue for the year is also projected to grow in the high-teens percentage, compared with a mid-teens percentage anticipated earlier. Analysts polled by Capital IQ expect $52.3 billion.

Price: 65.66, Change: +0.87, Percent Change: +1.34